Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals, a clinical‑stage biotech in San Diego, develops azenosertib, a Phase 3 ovarian‑cancer drug, and other small‑molecule cancer agents, backed by collaborations with Recurium, Mayo, Pfizer and Lilly.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 166
- HQ: San Diego
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.